Related Experiment Video
Updated: Mar 21, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Antibiotic Binding Drives Catalytic Activation of Aminoglycoside Kinase APH(2″)-Ia
Shane J Caldwell1, Yue Huang1, Albert M Berghuis2
1Department of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada; Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC H3G 0B1, Canada.
Abstract:
APH(2″)-Ia is a widely disseminated resistance factor frequently found in clinical isolates of Staphylococcus aureus and pathogenic enterococci, where it is constitutively expressed. APH(2″)-Ia confers high-level resistance to gentamicin and related aminoglycosides through phosphorylation of the antibiotic using guanosine triphosphate (GTP) as phosphate donor. We have determined crystal structures of the APH(2″)-Ia in complex with GTP analogs, guanosine diphosphate, and aminoglycosides. These structures collectively demonstrate that aminoglycoside binding to the GTP-bound kinase drives conformational changes that bring distant regions of the protein into contact. These changes in turn drive a switch of the triphosphate cofactor from an inactive, stabilized conformation to a catalytically competent active conformation. This switch has not been previously reported for antibiotic kinases or for the structurally related eukaryotic protein kinases. This catalytic triphosphate switch presents a means by which the enzyme can curtail wasteful hydrolysis of GTP in the absence of aminoglycosides, providing an evolutionary advantage to this enzyme.
Insights
Aminoglycoside resistance enzyme APH(2″)-Ia uses a novel triphosphate switch mechanism. This switch activates the enzyme only when aminoglycosides bind, preventing wasteful GTP hydrolysis and conferring an evolutionary advantage.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The enzyme aminoglycoside phosphotransferase (APH(2″)-Ia) is a common resistance factor in Staphylococcus aureus and enterococci.
- APH(2″)-Ia confers resistance to gentamicin and related aminoglycosides by phosphorylating them.
- This phosphorylation requires guanosine triphosphate (GTP) as a phosphate donor.
Purpose of the Study:
- To elucidate the structural mechanism of APH(2″)-Ia-mediated aminoglycoside resistance.
- To understand how GTP binding and aminoglycoside interaction regulate enzyme activity.
Main Methods:
- X-ray crystallography was used to determine the structures of APH(2″)-Ia.
- Structures were obtained for complexes with GTP analogs, guanosine diphosphate, and various aminoglycosides.
Main Results:
- Aminoglycoside binding induces conformational changes in APH(2″)-Ia, bringing distant protein regions together.
- These conformational changes facilitate a switch in GTP cofactor from an inactive to an active conformation.
- This catalytic triphosphate switch mechanism is novel for antibiotic kinases and related eukaryotic kinases.
Conclusions:
- The APH(2″)-Ia enzyme utilizes a unique catalytic triphosphate switch activated by aminoglycoside binding.
- This mechanism conserves GTP by preventing hydrolysis when the antibiotic is absent.
- The switch provides a significant evolutionary advantage to bacteria expressing this resistance factor.
More Related Videos
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
11:56Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Estimation of k and VD of Aminoglycosides
Mechanism of Antibiotic Resistance in MRSA
Antifungal Agents